On the

Press Releases

May 27, 2020 Assembly Biosciences Announces Management Transition
View HTML
PDF Version
May 26, 2020 Assembly Biosciences to Present During the Jefferies Virtual Healthcare Conference
View HTML
PDF Version
May 19, 2020 Assembly Biosciences Announces Move to Virtual-Only Annual Meeting of Stockholders on June 11, 2020
View HTML
PDF Version
May 07, 2020 Assembly Biosciences Reports Updates on Corporate Progress and First Quarter 2020 Financial Results
View HTML
PDF Version
May 04, 2020 Preclinical Data from Assembly Biosciences’ Microbiome Program in Ulcerative Colitis Featured in DDW 2020 Virtual Meeting Portal and Upcoming Journal Supplements
View HTML
PDF Version
May 01, 2020 Assembly Biosciences Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
View HTML
PDF Version
Apr 30, 2020 Assembly Biosciences to Host Conference Call and Webcast to Review HBV Portfolio Progress
View HTML
PDF Version
Apr 06, 2020 Research by Assembly Biosciences and Academic Collaborators Published in Hepatology Indicates cccDNA Turnover Time May Enable Hepatitis B Cures Following Finite Therapy
View HTML
PDF Version
Mar 31, 2020 Assembly Biosciences Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
View HTML
PDF Version
Mar 30, 2020 Assembly Biosciences Appoints Jason Okazaki as Chief Legal and Business Officer
View HTML
PDF Version